Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Seminars in Oncology|September 11, 1999
Immunologic approaches to the treatment of prostate cancerD T Harris, G R Matyas, L G Gomella, et al.Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1987
Elimination of immune suppressor mechanisms in humans by oxazaphosphorinesD Berd, M J MastrangeloBritish Journal of Cancer|December 1, 1981
Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophagesD Berd, M J MastrangeloCancer Research|June 15, 1987
Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subsetD Berd, M J MastrangeloCancer Research|May 15, 1987
Depletion of suppressor-cytotoxic T-lymphocytes by administration of a murine monoclonal antibodyD Berd, M J MastrangeloSeminars in Oncology|February 1, 1989
The pathophysiology and staging of cutaneous malignant melanomaS Schultz, M J MastrangeloCancer Investigation|January 1, 1988
Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamideD Berd, M J MastrangeloCancer Research|March 15, 1988
Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cellsD Berd, M J MastrangeloSurgical Endoscopy|March 31, 2000
Endoscopic retrograde cholangiopancreatography in the management of choledocholithiasisA E Park, M J MastrangeloCancer Immunology, Immunotherapy : CII|October 2, 1998
Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancerK K Bass, M J MastrangeloPageof 16